Ananya Bhattacharya

Ananya Bhattacharya has extensive experience in the pharmaceutical industry. Their most recent position was as the Head of Medical Affairs at Fennec Pharmaceuticals Inc, a role they started in March 2021. Prior to that, they worked at Bristol Myers Squibb for over 14 years, holding various roles within the medical and safety departments. These roles included Worldwide Medical Director for Safety (Immuno oncology), Global Lead for Safety & Risk Management Strategy (Immuno oncology portfolio), US Medical Strategy: IO Safety, US Risk Management Strategy Lead, Director Publication Policy & Education, Director, HQ Medical Writing, Associate Director, HQ Medical Writing, and Manager, Medical Publications. Before joining Bristol Myers Squibb, they also worked as a Medical Writer at Novo Nordisk A/S from March 2005 to July 2007.

Ananya Bhattacharya pursued their education from 1991 to 1998 at the Indian Institute of Science (IISc). During this period, they completed a Doctor of Philosophy (PhD) degree, however, the specific field of study is not mentioned.